Aim: In our study, the effect of the pandemic on the treatment of surgical oncology patients and its short-term results were investigated. The Coronavirus Disease 2019 pandemic has put a heavy burden on healthcare institutions. During this period, treatment of many diseases, including cancer patients, have been disrupted.
Methods: Our study was designed as a retrospective, observational study. It was investigated to what extent the treatment of patients receiving cancer treatment was affected and what changes were made in the management of patients diagnosed with cancer during the pandemic period.
Results: The 148 cancer cases were discussed at Multidisciplinary Meetings (MDM) held in our clinic between December 2019 and May 2020. Of the patients, 76 (51.4%) had gastrointestinal system malignancies, 39 (26.3%) had breast malignancies, and the rest had other malignancies. There was no statistically significant difference between the mean number of cancer cases discussed in MDMs held in pre-pandemic and pandemic periods. However, it was observed that there was a statistically significant decrease in the number of operations performed during the pandemic period (p
Key words: COVID-19; Surgical Oncology; Surgery; Management
|
